Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Metabolite clusters linking fatty liver disease to cardiovascular mortality in coronary heart disease patients

Nutrition Metabolism and Cardiovascular Diseases(2025)10.1016/j.numecd.2025.104535Source: DataRank Database

Metabolite clusters linking fatty liver disease to cardiovascular mortality in coronary heart disease patients is a research paper published in Nutrition Metabolism and Cardiovascular Diseases (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.00)OA: bronzeTopics (59)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Gerard Bryan Gonzales ORCID,Johanna M. Geleijnse ORCID,Fränzel J.B. van Duijnhoven ORCID,Luc Heerkens ORCID

Live enrichment

PubMed:41935853 OpenAlex:https://openalex.org/W7117146123

Jaap Schouten Foundation

Grant: JSF_SU_10_2018

Netherlands Heart Foundation

Grant: 200T401

National Institutes of Health

Grant: R01HL076200

FWCI

0.00

Citation Percentile

0.6%

bronzeLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

journalhttps://www.nmcd-journal.com/article/S0939-4753(25)00690-8/pdf

publisherhttps://www.nmcd-journal.com/article/S0939-4753(25)00690-8/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0939475325006908?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0939475325006908?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.numecd.2025.104535

Fields of Study

Liver Disease Diagnosis and TreatmentMetabolomics and Mass Spectrometry StudiesDiabetes, Cardiovascular Risks, and LipoproteinsHumansMaleFemaleCoronary DiseaseMiddle AgedBiomarkersMetabolomicsRisk AssessmentPrevalenceAgedPrognosisUK BiobankTime FactorsNon-alcoholic Fatty Liver DiseaseRisk FactorsHeart Disease Risk FactorsLipoproteins, VLDLCause of DeathUnited KingdomAmino AcidsProton Magnetic Resonance Spectroscopy

MeSH Terms

Heart Disease Risk FactorsUK BiobankAgedAmino AcidsCause of DeathCoronary DiseaseFemaleUnited KingdomHumansLipoproteins, VLDLMaleMiddle AgedPrognosisRisk FactorsTime FactorsBiomarkersPrevalenceRisk AssessmentMetabolomicsNon-alcoholic Fatty Liver DiseaseProton Magnetic Resonance Spectroscopy

Keywords

MetaboliteHazard ratioProportional hazards modelRisk factorDiseaseFatty liverCohort studyDocosahexaenoic acidConfidence intervalCardiovascular diseasesMetabolomicsExploratory Factor AnalysisFatty Liver DiseaseCoronary Heart Disease Patients

Sustainable Development Goals

SDG 0: Good health and well-being